Who owns ALTO NEUROSCIENCE INC?
- Ticker: ANRO
- CUSIP Number: 02157q109
Tip: Access positions for across all investors
Analyze quarterly positions in Alto Neuroscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Alto Neuroscience stock
Who bought or sold ALTO NEUROSCIENCE INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Falcon Edge Capital | 3.7M | $83M | 0% | Mar 2026 |
|
| Commodore Capital | 2.7M | $61M | 49% | Mar 2026 |
|
| Vestal Point Capital | 2.1M | $46M | -17% | Mar 2026 |
|
| Perceptive Advisors | 2.0M | $45M | 13% | Mar 2026 |
|
| Vanguard Group | 1.4M | $24M | 24% | Dec 2025 |
|
| Vanguard Capital Management | 1.2M | $27M | 100% | Mar 2026 |
|
| Franklin Resources | 1.1M | $25M | -2% | Mar 2026 |
|
| Vivo Capital | 1.0M | $23M | 0% | Mar 2026 |
|
| Armistice Capital | 912k | $21M | -44% | Mar 2026 |
|
| Millennium Management | 822k | $19M | 30% | Mar 2026 |
|
| 72 Investment Holdings | 668k | $15M | 0% | Mar 2026 |
|
| BlackRock | 666k | $15M | 10% | Mar 2026 |
|
| Ikarian Capital | 515k | $12M | 0% | Mar 2026 |
|
| Point72 Asset Management | 503k | $11M | -69% | Mar 2026 |
|
| VR Adviser | 500k | $11M | 100% | Mar 2026 |
|
| Susquehanna International | 497k | $8.8M | 219% | Dec 2025 |
|
| Alkeon Capital Management | 477k | $8.5M | 0% | Dec 2025 |
|
| Northern Trust | 474k | $8.4M | 3% | Dec 2025 |
|
| Jennison Associates | 386k | $8.7M | 100% | Mar 2026 |
|
| Integral Health Asset Management | 375k | $6.7M | -6% | Dec 2025 |
|
| Driehaus Capital Management | 337k | $6.0M | 100% | Dec 2025 |
|
| Geode Capital Management | 293k | $6.6M | 2% | Mar 2026 |
|
| Two Sigma Investments | 216k | $4.9M | 54% | Mar 2026 |
|
| Marshall Wace | 193k | $3.4M | -77% | Dec 2025 |
|
| AWM Investment Company | 170k | $3.8M | -24% | Mar 2026 |
|
| OrbiMed Advisors | 168k | $3.8M | 34% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 165k | $3.7M | 100% | Mar 2026 |
|
| Boothbay Fund Management | 139k | $3.1M | 0% | Mar 2026 |
|
| State Street Corporation | 131k | $2.3M | 27% | Dec 2025 |
|
| Qube Research & Technologies | 113k | $2.0M | 100% | Dec 2025 |
|
| Goldman Sachs Group | 105k | $2.4M | -33% | Mar 2026 |
|
| Renaissance Technologies | 97k | $1.7M | 29% | Dec 2025 |
|
| Stifel Financial | 86k | $1.9M | -1% | Mar 2026 |
|
| Almitas Capital | 79k | $1.8M | 0% | Mar 2026 |
|
| Jane Street | 78k | $1.8M | -68% | Mar 2026 |
|
| Bridgeway Capital Management | 78k | $1.4M | 0% | Dec 2025 |
|
| Ieq Capital | 75k | $1.3M | 20% | Dec 2025 |
|
| Wellington Management Company | 69k | $1.2M | 100% | Dec 2025 |
|
| Morgan Stanley | 69k | $1.5M | 5% | Mar 2026 |
|
| Acadian Asset Management | 60k | $1.3M | 4% | Mar 2026 |
|
| D. E. Shaw & Co | 45k | $1.0M | -64% | Mar 2026 |
|
| TD Asset Management | 44k | $985k | 100% | Mar 2026 |
|
| Hudson Bay Capital Management | 44k | $984k | 26% | Mar 2026 |
|
| AdvisorShares Investments | 41k | $922k | -7% | Mar 2026 |
|
| 683 Capital Management | 40k | $899k | -38% | Mar 2026 |
|
| Dimensional Fund Advisors | 39k | $884k | 26% | Mar 2026 |
|
| Brevan Howard Capital Management | 39k | $872k | 100% | Mar 2026 |
|
| Quantinno Capital Management | 36k | $811k | 1% | Mar 2026 |
|
| Balyasny Asset Management | 32k | $722k | 189% | Mar 2026 |
|
| Citadel Advisors | 31k | $699k | 4% | Mar 2026 |
|
| Barclays | 30k | $547k | 72262% | Dec 2025 |
|
| Squarepoint Ops | 30k | $674k | 100% | Mar 2026 |
|
| Allianz Asset Management | 29k | $641k | -34% | Mar 2026 |
|
| Bank of America Corporation | 26k | $577k | 100% | Mar 2026 |
|
| ALPS Advisors | 25k | $569k | -1% | Mar 2026 |
|
| Brown Advisory Holdings Incorporated | 25k | $562k | 0% | Mar 2026 |
|
| Y-Intercept | 24k | $538k | 100% | Mar 2026 |
|
| Manufacturers Life Insurance Company | 24k | $534k | 100% | Mar 2026 |
|
| University of Texas Investment Management Company | 22k | $499k | 0% | Mar 2026 |
|
| XTX Topco | 21k | $371k | 32% | Dec 2025 |
|
| Landscape Capital Management | 18k | $407k | 100% | Mar 2026 |
|
| UBS Group | 17k | $388k | -7% | Mar 2026 |
|
| Revisor Wealth Management | 17k | $385k | 100% | Mar 2026 |
|
| Charles Schwab Investment Management | 17k | $304k | 100% | Dec 2025 |
|
| SCS Capital Management | 17k | $379k | -50% | Mar 2026 |
|
| Polen Capital Management | 17k | $374k | 100% | Mar 2026 |
|
| JustInvest | 16k | $352k | -5% | Mar 2026 |
|
| Toronto-Dominion Bank | 13k | $302k | 100% | Mar 2026 |
|
| Ameriprise Financial | 13k | $300k | -1% | Mar 2026 |
|
| Hartland & Co | 13k | $299k | 100% | Mar 2026 |
|
| Catalyst Funds Management Pty | 11k | $256k | 100% | Mar 2026 |
|
| Bank Of Montreal | 11k | $255k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 11k | $239k | 100% | Mar 2026 |
|
| American Century Companies | 10k | $184k | 100% | Dec 2025 |
|
| Diametric Capital | 10k | $232k | 100% | Mar 2026 |
|
| OMERS Administration Corporation | 9.7k | $218k | -22% | Mar 2026 |
|
| Citigroup | 9.4k | $212k | 100% | Mar 2026 |
|
| FMR | 6.4k | $114k | -17% | Dec 2025 |
|
| Whittier Trust Co. of Nevada | 2.5k | $56k | 0% | Mar 2026 |
|
| Tower Research Capital | 2.0k | $35k | -17% | Dec 2025 |
|
| Rothschild Investment | 1.7k | $38k | -42% | Mar 2026 |
|
| Pnc Financial Services | 1.2k | $27k | -8% | Mar 2026 |
|
| Wells Fargo & Company | 790.00 | $18k | 3% | Mar 2026 |
|
| Federated Investors | 654.00 | $15k | -15% | Mar 2026 |
|
| EverSource Wealth Advisors | 628.00 | $14k | -5% | Mar 2026 |
|
| Torren Management | 558.00 | $13k | 100% | Mar 2026 |
|
| Group One Trading | 400.00 | $9.0k | -72% | Mar 2026 |
|
| NISA Investment Advisors | 338.00 | $7.6k | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 314.00 | $7.1k | -99% | Mar 2026 |
|
| Russell Investments | 306.00 | $6.9k | 0% | Mar 2026 |
|
| CWM | 154.00 | $3.0k | -83% | Dec 2025 |
|
| Global Retirement Partners | 150.00 | $2.7k | 100% | Dec 2025 |
|
| Us Bancorp | 113.00 | $2.0k | 100% | Dec 2025 |
|
| Cornerstone Financial Management | 69.00 | $1.6k | 100% | Mar 2026 |
|
| Signature | 41.00 | $921.999800 | -96% | Mar 2026 |
|
| Royal Bank of Canada | 41.00 | $999.998200 | -79% | Mar 2026 |
|
| Jones Financial Companies, L.L | 33.00 | $587.000700 | 100% | Dec 2025 |
|
| SHP Wealth Management | 25.00 | $562.000000 | 0% | Mar 2026 |
|
| SBI Securities | 12.00 | $270.000000 | 0% | Mar 2026 |
|
| Farther Finance Advisors | 11.00 | $257.999500 | -65% | Mar 2026 |
|
| SRS Capital Advisors | 5.00 | $112.000000 | 0% | Mar 2026 |
|
| Optiver Holding B.V. | 4.00 | $90.000000 | -80% | Mar 2026 |
|
Who sold out of Alto Neuroscience?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Peapod Lane Capital | Dec 2025 | 254k | $4.5M |
| Two Sigma Advisers | Dec 2025 | 160k | $2.8M |
| Artia Global Partners | Dec 2025 | 29k | $520k |
| Citizens Financial Group | Dec 2025 | 28k | $502k |
| AlphaCore Capital | Dec 2025 | 20k | $356k |
| ExodusPoint Capital Management | Dec 2025 | 19k | $334k |
| Springbok Capital Management | Sep 2025 | 11k | $46k |
| Quest Partners | Dec 2025 | 3.8k | $68k |
| Advisory Services Network | Sep 2025 | 802.00 | $3.2k |
| Fortitude Family Office | Dec 2025 | 511.00 | $9.1k |
| North Star Investment Management | Dec 2025 | 174.00 | $3.1k |
| Advisor Group Holdings | Sep 2025 | 47.00 | $189.001100 |